Brief: Orexo Q3 Revenue AT SEK 118.7 Mln, Guidance Unchanged
Oct 23 (Reuters) - Orexo AB ORX.ST: Q3 REVENUE SEK 118.7 MILLION Q3 EPS SEK -0.86 Q3 EBITDA SEK -9.8 MILLION Q3 ADJUSTED EPS SEK -0.86 Q3 EBIT SEK -21.1 MILLION 2025 FINANCIAL OUTLOOK REITERATED. EXPECT ZUBSOLV SALES TO IMPROVE IN Q4 CONSISTENTLY WITH HISTORICAL SEASONAL PATTERNS Source text: ID:nMFNhVNYr Further company coverage: ORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens